Xiuning Le on Muck Rack

Xiuning Le

Boston
As seen in: Nature, Memory Studies, MDPI, The BMJ, The New England Journal of Medicine, Cell Press, Dove Medical Press, Texas Medical Center, Future Medicine, ONCOLOGY journal and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Xiuning

Contact Xiuning, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma

|
By Amaury Daste, Xiuning Le, Amani Makkouk
| The BMJ Verified
Introduction Head and neck cancers have a high mortality rate, with over 430,000 deaths annually.
Open in Who Shared Issue with article?

Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches - Nature Reviews Clinical Oncology

|
By Fei Zhou, Xiuning Le
| Nature Verified
Abstract Resistance to EGFR tyrosine kinase inhibitors (TKIs) remains a major obstacle in the clinical management of EGFR-mutant non-small-cell lung cancer (NSCLC).
Open in Who Shared Issue with article?

An Oncodermatologist’s Perspective on Dermatological Toxicities in Breast Cancer

|
By Sara A. Hurvitz, Xiuning Le, Erica L. Mayer, Tim Cortese
| ONCOLOGY journal Verified
"Before [onco-dermatology] was created, skin toxicities, among other things, were one of the most common reasons that cancer-related therapies were stopped,” Allireza Alloo, MD, said in a recent interview with Cancer Network. As patients receive treatment for breast cancer, whether it is chemotherapy or targeted therapy, toxicities will occur. Among these toxicities, dermatologic adverse events (dAEs) affect many and may require specialists to be properly managed.
Open in Who Shared Issue with article?
See all 34 licensed articles (78 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified